Healthcare Resource Utilization of Second-Generation Long-Acting Injectable Antipsychotics in Schizophrenia: Risperidone versus Paliperidone Palmitate.

CONCLUSIONS: These findings highlight the value of once-monthly paliperidone palmitate in the treatment of patients with schizophrenia. PMID: 27479694 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research